SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000902664-23-003304
Filing Date
2023-05-25
Accepted
2023-05-25 16:39:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMBRX BIOPHARMA INC. p23-1647sc13da.htm SC 13D/A 55833
  Complete submission text file 0000902664-23-003304.txt   57356
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Subject) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92634 | Film No.: 23961433
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address WHITLEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR
Business Address WHITLEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR (212) 729-7524
Darwin Global Management, Ltd. (Filed by) CIK: 0001839209 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13D/A